Structure

Physi-Chem Properties

Molecular Weight:  502.37
Volume:  540.628
LogP:  4.417
LogD:  4.2
LogS:  -3.706
# Rotatable Bonds:  6
TPSA:  97.99
# H-Bond Aceptor:  5
# H-Bond Donor:  4
# Rings:  5
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.364
Synthetic Accessibility Score:  6.044
Fsp3:  0.903
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.561
MDCK Permeability:  8.649969458929263e-06
Pgp-inhibitor:  0.002
Pgp-substrate:  0.32
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.674
30% Bioavailability (F30%):  0.907

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.586
Plasma Protein Binding (PPB):  91.77027893066406%
Volume Distribution (VD):  0.478
Pgp-substrate:  7.91701078414917%

ADMET: Metabolism

CYP1A2-inhibitor:  0.007
CYP1A2-substrate:  0.459
CYP2C19-inhibitor:  0.007
CYP2C19-substrate:  0.821
CYP2C9-inhibitor:  0.079
CYP2C9-substrate:  0.189
CYP2D6-inhibitor:  0.002
CYP2D6-substrate:  0.082
CYP3A4-inhibitor:  0.88
CYP3A4-substrate:  0.3

ADMET: Excretion

Clearance (CL):  3.759
Half-life (T1/2):  0.394

ADMET: Toxicity

hERG Blockers:  0.059
Human Hepatotoxicity (H-HT):  0.463
Drug-inuced Liver Injury (DILI):  0.025
AMES Toxicity:  0.013
Rat Oral Acute Toxicity:  0.568
Maximum Recommended Daily Dose:  0.512
Skin Sensitization:  0.309
Carcinogencity:  0.543
Eye Corrosion:  0.018
Eye Irritation:  0.02
Respiratory Toxicity:  0.976

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC234564

Natural Product ID:  NPC234564
Common Name*:   NMGCAUZQKXGUAO-ITRBRHPWSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  NMGCAUZQKXGUAO-ITRBRHPWSA-N
Standard InCHI:  InChI=1S/C31H50O5/c1-17(2)18(3)8-9-19(4)24-21(33)15-28(6)25-20(32)14-22-29(7,26(35)36)23(34)10-11-30(22)16-31(25,30)13-12-27(24,28)5/h17,19-25,32-34H,3,8-16H2,1-2,4-7H3,(H,35,36)/t19-,20+,21+,22+,23+,24+,25+,27-,28+,29+,30-,31+/m1/s1
SMILES:  C=C(C(C)C)CC[C@H]([C@H]1[C@@H](O)C[C@@]2([C@]1(C)CC[C@@]13[C@H]2[C@@H](O)C[C@@H]2[C@]3(C1)CC[C@@H]([C@@]2(C)C(=O)O)O)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL468879
PubChem CID:   10918144
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0002321] Cycloartanols and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO19294 Acalypha communis Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[12088430]
NPO19294 Acalypha communis Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 16.0 ug.mL-1 PMID[507794]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC > 128.0 ug.mL-1 PMID[507794]
NPT1531 Organism Enterococcus faecium Enterococcus faecium MIC = 8.0 ug.mL-1 PMID[507794]
NPT19 Organism Escherichia coli Escherichia coli MIC > 128.0 ug.mL-1 PMID[507794]
NPT79 Organism Bacillus subtilis Bacillus subtilis MIC = 16.0 ug.mL-1 PMID[507794]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC234564 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9667 High Similarity NPC288906
0.9667 High Similarity NPC263135
0.9468 High Similarity NPC193934
0.9468 High Similarity NPC271980
0.9255 High Similarity NPC37047
0.9255 High Similarity NPC41971
0.9255 High Similarity NPC94906
0.9255 High Similarity NPC180733
0.9239 High Similarity NPC266431
0.9213 High Similarity NPC146937
0.9158 High Similarity NPC71706
0.9158 High Similarity NPC75941
0.9149 High Similarity NPC472028
0.9062 High Similarity NPC124544
0.8969 High Similarity NPC312900
0.8969 High Similarity NPC470310
0.8913 High Similarity NPC198242
0.8913 High Similarity NPC211403
0.8901 High Similarity NPC213832
0.8901 High Similarity NPC57954
0.8889 High Similarity NPC134197
0.8854 High Similarity NPC108371
0.883 High Similarity NPC205173
0.8817 High Similarity NPC244356
0.8817 High Similarity NPC224060
0.88 High Similarity NPC211224
0.8791 High Similarity NPC471900
0.8791 High Similarity NPC183374
0.8791 High Similarity NPC211162
0.8788 High Similarity NPC265127
0.8778 High Similarity NPC302111
0.8763 High Similarity NPC289148
0.8763 High Similarity NPC52899
0.8763 High Similarity NPC163963
0.8737 High Similarity NPC329910
0.8723 High Similarity NPC470385
0.8723 High Similarity NPC470386
0.8687 High Similarity NPC201763
0.8681 High Similarity NPC264005
0.8681 High Similarity NPC269360
0.8673 High Similarity NPC148628
0.8673 High Similarity NPC88203
0.8673 High Similarity NPC304832
0.8673 High Similarity NPC76866
0.8673 High Similarity NPC246736
0.8673 High Similarity NPC214946
0.8673 High Similarity NPC286519
0.866 High Similarity NPC287676
0.8646 High Similarity NPC469810
0.8646 High Similarity NPC253586
0.8632 High Similarity NPC470232
0.8632 High Similarity NPC470229
0.8632 High Similarity NPC48330
0.8617 High Similarity NPC144739
0.8617 High Similarity NPC181594
0.8617 High Similarity NPC473690
0.8617 High Similarity NPC477855
0.8617 High Similarity NPC471902
0.8617 High Similarity NPC287118
0.8602 High Similarity NPC169933
0.86 High Similarity NPC295366
0.86 High Similarity NPC37600
0.8586 High Similarity NPC469985
0.8586 High Similarity NPC87927
0.8571 High Similarity NPC80590
0.8571 High Similarity NPC253886
0.8571 High Similarity NPC2783
0.8571 High Similarity NPC46848
0.8571 High Similarity NPC121218
0.8557 High Similarity NPC474793
0.8557 High Similarity NPC16911
0.8557 High Similarity NPC471038
0.8557 High Similarity NPC78427
0.8544 High Similarity NPC470281
0.8542 High Similarity NPC13949
0.8542 High Similarity NPC173272
0.8542 High Similarity NPC470387
0.8542 High Similarity NPC327788
0.8526 High Similarity NPC475118
0.8526 High Similarity NPC47853
0.8526 High Similarity NPC292374
0.8526 High Similarity NPC129004
0.8526 High Similarity NPC91772
0.8526 High Similarity NPC261333
0.8526 High Similarity NPC289539
0.8526 High Similarity NPC111524
0.8526 High Similarity NPC153775
0.8526 High Similarity NPC104371
0.8526 High Similarity NPC277399
0.8526 High Similarity NPC101233
0.8526 High Similarity NPC29247
0.8526 High Similarity NPC215271
0.8515 High Similarity NPC263729
0.8511 High Similarity NPC471901
0.8511 High Similarity NPC299185
0.8511 High Similarity NPC475416
0.8511 High Similarity NPC476168
0.85 High Similarity NPC98603
0.8495 Intermediate Similarity NPC56962
0.8495 Intermediate Similarity NPC24772
0.8495 Intermediate Similarity NPC24705
0.8495 Intermediate Similarity NPC116146
0.8485 Intermediate Similarity NPC170615
0.8485 Intermediate Similarity NPC275990
0.8478 Intermediate Similarity NPC259009
0.8478 Intermediate Similarity NPC57469
0.8478 Intermediate Similarity NPC33768
0.8462 Intermediate Similarity NPC264317
0.8462 Intermediate Similarity NPC294438
0.8454 Intermediate Similarity NPC170978
0.8444 Intermediate Similarity NPC245866
0.8438 Intermediate Similarity NPC231060
0.8438 Intermediate Similarity NPC98639
0.8438 Intermediate Similarity NPC210214
0.8438 Intermediate Similarity NPC138245
0.8438 Intermediate Similarity NPC84018
0.8431 Intermediate Similarity NPC163216
0.8421 Intermediate Similarity NPC291373
0.8421 Intermediate Similarity NPC294263
0.8404 Intermediate Similarity NPC261994
0.8404 Intermediate Similarity NPC100313
0.8404 Intermediate Similarity NPC80401
0.8404 Intermediate Similarity NPC470378
0.8404 Intermediate Similarity NPC180849
0.8404 Intermediate Similarity NPC149761
0.84 Intermediate Similarity NPC216114
0.8387 Intermediate Similarity NPC474719
0.8387 Intermediate Similarity NPC16377
0.8384 Intermediate Similarity NPC39683
0.8384 Intermediate Similarity NPC471790
0.8384 Intermediate Similarity NPC295276
0.8384 Intermediate Similarity NPC236585
0.837 Intermediate Similarity NPC70661
0.837 Intermediate Similarity NPC12774
0.8367 Intermediate Similarity NPC98837
0.8367 Intermediate Similarity NPC38296
0.8367 Intermediate Similarity NPC477854
0.8367 Intermediate Similarity NPC28864
0.8367 Intermediate Similarity NPC20479
0.8367 Intermediate Similarity NPC162459
0.8367 Intermediate Similarity NPC38471
0.8365 Intermediate Similarity NPC470311
0.8365 Intermediate Similarity NPC270586
0.8351 Intermediate Similarity NPC200054
0.8351 Intermediate Similarity NPC135548
0.8351 Intermediate Similarity NPC140242
0.8351 Intermediate Similarity NPC29410
0.8351 Intermediate Similarity NPC264979
0.8351 Intermediate Similarity NPC477853
0.835 Intermediate Similarity NPC257082
0.835 Intermediate Similarity NPC285298
0.8333 Intermediate Similarity NPC280804
0.8333 Intermediate Similarity NPC302008
0.8333 Intermediate Similarity NPC191094
0.8317 Intermediate Similarity NPC84928
0.8317 Intermediate Similarity NPC47281
0.8316 Intermediate Similarity NPC250753
0.8316 Intermediate Similarity NPC470230
0.8315 Intermediate Similarity NPC477851
0.83 Intermediate Similarity NPC15396
0.8298 Intermediate Similarity NPC475921
0.8298 Intermediate Similarity NPC474704
0.8298 Intermediate Similarity NPC220498
0.8283 Intermediate Similarity NPC470388
0.8283 Intermediate Similarity NPC293866
0.828 Intermediate Similarity NPC153604
0.828 Intermediate Similarity NPC472497
0.8265 Intermediate Similarity NPC10864
0.8265 Intermediate Similarity NPC111187
0.8265 Intermediate Similarity NPC190554
0.8265 Intermediate Similarity NPC190080
0.8261 Intermediate Similarity NPC201655
0.8261 Intermediate Similarity NPC76518
0.8261 Intermediate Similarity NPC190704
0.8261 Intermediate Similarity NPC471034
0.8252 Intermediate Similarity NPC231278
0.8252 Intermediate Similarity NPC218123
0.8252 Intermediate Similarity NPC112895
0.8247 Intermediate Similarity NPC279974
0.8242 Intermediate Similarity NPC471037
0.8235 Intermediate Similarity NPC138908
0.8235 Intermediate Similarity NPC278628
0.8235 Intermediate Similarity NPC28791
0.8235 Intermediate Similarity NPC231530
0.8235 Intermediate Similarity NPC50535
0.8235 Intermediate Similarity NPC285927
0.8235 Intermediate Similarity NPC200957
0.8229 Intermediate Similarity NPC59350
0.8229 Intermediate Similarity NPC470375
0.8229 Intermediate Similarity NPC59170
0.8229 Intermediate Similarity NPC206810
0.8229 Intermediate Similarity NPC476189
0.8229 Intermediate Similarity NPC470376
0.8218 Intermediate Similarity NPC122811
0.8218 Intermediate Similarity NPC139347
0.8218 Intermediate Similarity NPC209298
0.8218 Intermediate Similarity NPC277074
0.8211 Intermediate Similarity NPC77756
0.8211 Intermediate Similarity NPC46758
0.8191 Intermediate Similarity NPC160304

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC234564 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8462 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.809 Intermediate Similarity NPD6697 Approved
0.809 Intermediate Similarity NPD6114 Approved
0.809 Intermediate Similarity NPD6118 Approved
0.809 Intermediate Similarity NPD6115 Approved
0.7938 Intermediate Similarity NPD8035 Phase 2
0.7938 Intermediate Similarity NPD8034 Phase 2
0.7885 Intermediate Similarity NPD6402 Approved
0.7885 Intermediate Similarity NPD5739 Approved
0.7885 Intermediate Similarity NPD7128 Approved
0.7885 Intermediate Similarity NPD6675 Approved
0.7865 Intermediate Similarity NPD6117 Approved
0.7778 Intermediate Similarity NPD6116 Phase 1
0.7736 Intermediate Similarity NPD6899 Approved
0.7736 Intermediate Similarity NPD7320 Approved
0.7736 Intermediate Similarity NPD6881 Approved
0.7732 Intermediate Similarity NPD5328 Approved
0.7723 Intermediate Similarity NPD4755 Approved
0.7664 Intermediate Similarity NPD6372 Approved
0.7664 Intermediate Similarity NPD6373 Approved
0.766 Intermediate Similarity NPD4788 Approved
0.7647 Intermediate Similarity NPD7638 Approved
0.7642 Intermediate Similarity NPD5697 Approved
0.7642 Intermediate Similarity NPD5701 Approved
0.764 Intermediate Similarity NPD6113 Clinical (unspecified phase)
0.7593 Intermediate Similarity NPD7290 Approved
0.7593 Intermediate Similarity NPD4634 Approved
0.7593 Intermediate Similarity NPD7102 Approved
0.7593 Intermediate Similarity NPD6883 Approved
0.7576 Intermediate Similarity NPD6079 Approved
0.7573 Intermediate Similarity NPD7640 Approved
0.7573 Intermediate Similarity NPD7639 Approved
0.7573 Intermediate Similarity NPD5285 Approved
0.7573 Intermediate Similarity NPD5286 Approved
0.7573 Intermediate Similarity NPD4700 Approved
0.7573 Intermediate Similarity NPD4696 Approved
0.7556 Intermediate Similarity NPD3703 Phase 2
0.7523 Intermediate Similarity NPD8130 Phase 1
0.7523 Intermediate Similarity NPD6617 Approved
0.7523 Intermediate Similarity NPD6650 Approved
0.7523 Intermediate Similarity NPD6869 Approved
0.7523 Intermediate Similarity NPD6649 Approved
0.7523 Intermediate Similarity NPD6847 Approved
0.75 Intermediate Similarity NPD6013 Approved
0.75 Intermediate Similarity NPD6012 Approved
0.75 Intermediate Similarity NPD6014 Approved
0.7456 Intermediate Similarity NPD6319 Approved
0.7455 Intermediate Similarity NPD8297 Approved
0.7455 Intermediate Similarity NPD6882 Approved
0.7429 Intermediate Similarity NPD4633 Approved
0.7429 Intermediate Similarity NPD5225 Approved
0.7429 Intermediate Similarity NPD5224 Approved
0.7429 Intermediate Similarity NPD5226 Approved
0.7429 Intermediate Similarity NPD5211 Phase 2
0.7407 Intermediate Similarity NPD6011 Approved
0.74 Intermediate Similarity NPD7515 Phase 2
0.7396 Intermediate Similarity NPD4786 Approved
0.7387 Intermediate Similarity NPD4632 Approved
0.7383 Intermediate Similarity NPD6008 Approved
0.7379 Intermediate Similarity NPD6084 Phase 2
0.7379 Intermediate Similarity NPD6083 Phase 2
0.7364 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7358 Intermediate Similarity NPD5175 Approved
0.7358 Intermediate Similarity NPD5174 Approved
0.735 Intermediate Similarity NPD7492 Approved
0.7333 Intermediate Similarity NPD5223 Approved
0.7327 Intermediate Similarity NPD4202 Approved
0.7327 Intermediate Similarity NPD6399 Phase 3
0.7311 Intermediate Similarity NPD7736 Approved
0.7304 Intermediate Similarity NPD6054 Approved
0.7304 Intermediate Similarity NPD6059 Approved
0.729 Intermediate Similarity NPD5141 Approved
0.7288 Intermediate Similarity NPD6616 Approved
0.7282 Intermediate Similarity NPD4697 Phase 3
0.7282 Intermediate Similarity NPD5222 Approved
0.7282 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7282 Intermediate Similarity NPD5221 Approved
0.7265 Intermediate Similarity NPD7604 Phase 2
0.725 Intermediate Similarity NPD7319 Approved
0.7245 Intermediate Similarity NPD3618 Phase 1
0.7227 Intermediate Similarity NPD7078 Approved
0.7227 Intermediate Similarity NPD8293 Discontinued
0.7222 Intermediate Similarity NPD4809 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD4808 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD4768 Approved
0.7222 Intermediate Similarity NPD4767 Approved
0.7216 Intermediate Similarity NPD3665 Phase 1
0.7216 Intermediate Similarity NPD3666 Approved
0.7216 Intermediate Similarity NPD3133 Approved
0.7212 Intermediate Similarity NPD5173 Approved
0.72 Intermediate Similarity NPD4753 Phase 2
0.7196 Intermediate Similarity NPD4754 Approved
0.7193 Intermediate Similarity NPD6009 Approved
0.7188 Intermediate Similarity NPD3667 Approved
0.7184 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD6370 Approved
0.7158 Intermediate Similarity NPD7525 Registered
0.7143 Intermediate Similarity NPD7507 Approved
0.7111 Intermediate Similarity NPD4245 Approved
0.7111 Intermediate Similarity NPD4244 Approved
0.7105 Intermediate Similarity NPD6274 Approved
0.7103 Intermediate Similarity NPD7632 Discontinued
0.71 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7094 Intermediate Similarity NPD6016 Approved
0.7094 Intermediate Similarity NPD6015 Approved
0.7091 Intermediate Similarity NPD4729 Approved
0.7091 Intermediate Similarity NPD5128 Approved
0.7091 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD4730 Approved
0.7087 Intermediate Similarity NPD7748 Approved
0.708 Intermediate Similarity NPD8133 Approved
0.7071 Intermediate Similarity NPD7146 Approved
0.7071 Intermediate Similarity NPD6409 Approved
0.7071 Intermediate Similarity NPD6684 Approved
0.7071 Intermediate Similarity NPD5330 Approved
0.7071 Intermediate Similarity NPD7521 Approved
0.7071 Intermediate Similarity NPD7334 Approved
0.7069 Intermediate Similarity NPD7100 Approved
0.7069 Intermediate Similarity NPD7101 Approved
0.7059 Intermediate Similarity NPD6411 Approved
0.7043 Intermediate Similarity NPD7115 Discovery
0.7034 Intermediate Similarity NPD5988 Approved
0.7019 Intermediate Similarity NPD5695 Phase 3
0.7 Intermediate Similarity NPD3698 Phase 2
0.7 Intermediate Similarity NPD3699 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD3700 Clinical (unspecified phase)
0.6989 Remote Similarity NPD3702 Approved
0.6983 Remote Similarity NPD6335 Approved
0.6981 Remote Similarity NPD5696 Approved
0.6964 Remote Similarity NPD5247 Approved
0.6964 Remote Similarity NPD5248 Approved
0.6964 Remote Similarity NPD5250 Approved
0.6964 Remote Similarity NPD5249 Phase 3
0.6964 Remote Similarity NPD5251 Approved
0.6949 Remote Similarity NPD6908 Approved
0.6949 Remote Similarity NPD6909 Approved
0.6949 Remote Similarity NPD5983 Phase 2
0.6931 Remote Similarity NPD6903 Approved
0.6903 Remote Similarity NPD5217 Approved
0.6903 Remote Similarity NPD5216 Approved
0.6903 Remote Similarity NPD5215 Approved
0.69 Remote Similarity NPD3574 Clinical (unspecified phase)
0.6897 Remote Similarity NPD6317 Approved
0.6893 Remote Similarity NPD7637 Suspended
0.6887 Remote Similarity NPD7902 Approved
0.6863 Remote Similarity NPD6101 Approved
0.6863 Remote Similarity NPD5764 Clinical (unspecified phase)
0.686 Remote Similarity NPD6336 Discontinued
0.6857 Remote Similarity NPD5210 Approved
0.6857 Remote Similarity NPD4629 Approved
0.6848 Remote Similarity NPD6081 Approved
0.6848 Remote Similarity NPD5777 Approved
0.6847 Remote Similarity NPD6412 Phase 2
0.6838 Remote Similarity NPD6313 Approved
0.6838 Remote Similarity NPD6314 Approved
0.6837 Remote Similarity NPD4221 Approved
0.6837 Remote Similarity NPD4223 Phase 3
0.6827 Remote Similarity NPD5779 Approved
0.6827 Remote Similarity NPD5778 Approved
0.6814 Remote Similarity NPD5135 Approved
0.6814 Remote Similarity NPD5169 Approved
0.6814 Remote Similarity NPD5134 Clinical (unspecified phase)
0.681 Remote Similarity NPD6868 Approved
0.6804 Remote Similarity NPD5368 Approved
0.68 Remote Similarity NPD5329 Approved
0.6765 Remote Similarity NPD6672 Approved
0.6765 Remote Similarity NPD5737 Approved
0.6762 Remote Similarity NPD6001 Approved
0.6754 Remote Similarity NPD5127 Approved
0.6752 Remote Similarity NPD8295 Clinical (unspecified phase)
0.6748 Remote Similarity NPD6033 Approved
0.6739 Remote Similarity NPD4789 Approved
0.6737 Remote Similarity NPD3701 Clinical (unspecified phase)
0.6733 Remote Similarity NPD6098 Approved
0.6731 Remote Similarity NPD5281 Approved
0.6731 Remote Similarity NPD5284 Approved
0.6703 Remote Similarity NPD5360 Phase 3
0.6703 Remote Similarity NPD5361 Clinical (unspecified phase)
0.67 Remote Similarity NPD3668 Phase 3
0.67 Remote Similarity NPD4197 Approved
0.6699 Remote Similarity NPD6673 Approved
0.6699 Remote Similarity NPD6080 Approved
0.6699 Remote Similarity NPD6904 Approved
0.6697 Remote Similarity NPD1700 Approved
0.6696 Remote Similarity NPD6053 Discontinued
0.6694 Remote Similarity NPD8328 Phase 3
0.6667 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6667 Remote Similarity NPD8170 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6435 Approved
0.6667 Remote Similarity NPD4224 Phase 2
0.6637 Remote Similarity NPD5168 Approved
0.6632 Remote Similarity NPD7339 Approved
0.6632 Remote Similarity NPD6942 Approved
0.663 Remote Similarity NPD4267 Clinical (unspecified phase)
0.6606 Remote Similarity NPD8418 Phase 2
0.6604 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6604 Remote Similarity NPD7900 Approved
0.6581 Remote Similarity NPD5167 Approved
0.6579 Remote Similarity NPD4061 Clinical (unspecified phase)
0.6569 Remote Similarity NPD5786 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data